4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-26-080397
Chief Scientific Officer gave up 2,150 shares (to pay taxes)
- Chief Scientific Officer acquired 4,445 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Garfield Alastair Chief Scientific Officer | 2026-07-01 | Option exercise | +4,445 | 12,208 | D | ||
| Garfield Alastair Chief Scientific Officer | 2026-07-01 | Shares withheld for taxes | −2,150 | $110.41 | $237,382 | 10,058 | D |
| Derivatives | |||||||
| Garfield Alastair Chief Scientific Officer | 2026-07-01 | Option exercise · Restricted Stock Units | −4,445 | 8,888 | D | ||
Loading xslF345X06/tm2619643-1_4seq1.xml…